PERSPECTA

News from every angle

← Back to headlines

NeuroSense Therapeutics receives Nasdaq listing deficiency notices

NeuroSense Therapeutics has received notices from Nasdaq concerning its compliance with the exchange's listing requirements.

3 Apr, 14:54 — 3 Apr, 14:54
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed6d ago

NeuroSense Therapeutics receives Nasdaq notices over listing requirements

Read full article →

Related Stories

Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk

just now

Artemis II Astronauts Return to Earth After Moon Mission

just now

Philippine PCO to Launch Website for Reporting Fake News

just now

Group Warns Social Media Ban for Minors May Displace Harm

just now